suggested that the overexpression of FGFR1 in NSCLC is better explained by promoter demethylation or downregulation of specific miRNAs, which may be related to the poor effect of FGFR TKIs in some patients with FGFR amplification. The gene discussed is FGFR1; the disease is non-small cell lung carcinoma.